Related Experiment Video
Updated: Jun 12, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Differential effects of the putative GBF1 inhibitors Golgicide A and AG1478 on enterovirus replication
Lonneke van der Linden1, Hilde M van der Schaar, Kjerstin H W Lanke
1Department of Medical Microbiology, Nijmegen Centre for Molecular Life Sciences and Nijmegen Institute for Infection, Inflammation and Immunity, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
Abstract:
The genus Enterovirus, belonging to the family Picornaviridae, includes well-known pathogens, such as poliovirus, coxsackievirus, and rhinovirus. Brefeldin A (BFA) impedes replication of several enteroviruses through inhibition of Golgi-specific BFA resistance factor 1 (GBF1), a regulator of secretory pathway integrity and transport. GBF1 mediates the GTP exchange of Arf1, which in activated form recruits coatomer protein complex I (COP-I) to Golgi vesicles, a process important in transport between the endoplasmic reticulum and Golgi vesicles. Recently, the drugs AG1478 and Golgicide A (GCA) were put forward as new inhibitors of GBF1. In this study, we investigated the effects of these putative GBF1 inhibitors on secretory pathway function and enterovirus replication. We show that both drugs induced fragmentation of the Golgi vesicles and caused dissociation of Arf1 and COP-I from Golgi membranes, yet they differed in their effect on GBF1 localization. The effects of AG1478, but not those of GCA, could be countered by overexpression of Arf1, indicating a difference in their molecular mechanism of action. Consistent with this idea, we observed that GCA drastically reduced replication of coxsackievirus B3 (CVB3) and other human enterovirus species, whereas AG1478 had no effect at all on enterovirus replication. Time-of-addition studies and analysis of RNA replication using a subgenomic replicon both showed that GCA suppresses RNA replication of CVB3, which could be countered by overexpression of GBF1. These results indicate that, in contrast to AG1478, GCA inhibits CVB3 RNA replication by targeting GBF1. AG1478 and GCA may be valuable tools to further dissect enterovirus replication.
Insights
Golgicide A (GCA) inhibits enterovirus replication by targeting Golgi-specific BFA resistance factor 1 (GBF1). Unlike AG1478, GCA suppresses viral RNA replication, making it a potential tool for studying enteroviruses.
Area of Science:
- Virology
- Cell Biology
- Drug Discovery
Background:
- Enteroviruses, including poliovirus and coxsackievirus, are significant human pathogens.
- Brefeldin A (BFA) inhibits enterovirus replication by targeting Golgi-specific BFA resistance factor 1 (GBF1), crucial for secretory pathway function.
- GBF1 regulates Arf1 GTP exchange, influencing coatomer protein complex I (COP-I) recruitment for vesicle transport.
Purpose of the Study:
- To investigate the effects of novel GBF1 inhibitors, AG1478 and Golgicide A (GCA), on secretory pathway function and enterovirus replication.
- To elucidate the molecular mechanisms by which AG1478 and GCA affect GBF1 and viral replication.
Main Methods:
- Treatment of cells with AG1478 and GCA to assess effects on Golgi vesicles, Arf1, and COP-I localization.
- Overexpression of Arf1 and GBF1 to determine rescue effects on drug-induced inhibition.
- Analysis of coxsackievirus B3 (CVB3) replication and RNA synthesis using time-of-addition studies and subgenomic replicons.
Main Results:
- Both AG1478 and GCA induced Golgi vesicle fragmentation and dissociation of Arf1/COP-I from Golgi membranes.
- GCA, but not AG1478, significantly reduced CVB3 and other enterovirus replication.
- GCA suppressed CVB3 RNA replication, an effect reversible by GBF1 overexpression, indicating direct targeting of GBF1.
Conclusions:
- Golgicide A (GCA) directly inhibits enterovirus RNA replication by targeting GBF1, unlike AG1478.
- AG1478 and GCA represent valuable pharmacological tools for dissecting enterovirus replication mechanisms.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial DNA Synthesis

